Key Highlights
- FDA to announce regulatory changes related to Covid vaccine claims.
- All 12 former FDA heads have criticized the proposed changes.
- The updates represent a major shift from previous FDA priorities.
- The initiative is led by Robert F. Kennedy Jr., Secretary of HHS.
- Unconfirmed claims of vaccine-linked deaths are the catalyst for the changes.


